Skip to main content

Glenn Sblendorio

Equibles does not estimate personal net worth.

Get an email with a short summary when 4D Molecular Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get FDMT alerts

About Glenn Sblendorio

Glenn Sblendorio is recorded as Board Member at 4D Molecular Therapeutics, Inc. (FDMT) since January 1, 2026. The newest filing on record that lists Glenn Sblendorio as Board Member at 4D Molecular Therapeutics, Inc. (FDMT) is dated April 28, 2026. 4D Molecular Therapeutics, Inc. reported in an 8-K filed January 7, 2026 that Glenn Sblendorio was appointed Class I director, effective January 5, 2026. 4D Molecular Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at 4D Molecular Therapeutics, Inc. includes David Kirn (CEO and Board Member), David Kirn, M.D. (CEO), Ashoo Gupta (CFO) and 7 others.

“Effective as of January 5, 2026, the Board appointed Glenn Sblendorio to the Board as a Class I director, to serve for a term expiring at the Company's 2027 annual meeting of stockholders.”
4D Molecular Therapeutics, Inc. Form 8-K, filed January 7, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at 4D Molecular Therapeutics, Inc.

Recent activity